The following is a summary of “Longitudinal integrated proteomic and metabolomic skin changes in atopic dermatitis patients ...

The SHHS was approved by the institutional review boards of the participating institutions. Appropriate informed consent was obtained, and procedures conformed to the Declaration of Helsinki on ...

1 The First Clinical Medical College, Shanxi Medical University, Taiyuan, Shanxi, China 2 Department of Dermatology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China A 42 year-old ...

new shops and products, travel destinations, art and cultural events, celebrity style, and high-end real estate as well as access to print features and images from the AD archives.

Dupilumab vs conventional AD therapies had less risk for anxiety, depression, and adjustment and sleep disorders, especially among Black patients. Patients with atopic dermatitis (AD) who were ...

In our community-based outpatient psychiatric clinic, we observed that high dosages (up to 540mg administered once weekly) of entericcoated fluoxetine were effective and well tolerated as ...

Netflix has introduced a new type of extra member account: extra members with ads. The streamer announced the new offering in a shareholder letter on Tuesday before its fourth-quarter earnings call.

An advocacy group founded by former Vice President Mike Pence launched a six-figure ad campaign Wednesday opposing President Trump’s nomination of Robert F. Kennedy Jr. to lead the Department of ...

So every company wants a piece of the pie. To stand out, companies put a ton of time, effort and cash into creating memorable ads. In the age of social media, making an impact is even more crucial.

In 2019, following the steps of previously established social media giants such as Facebook, Twitter, and Instagram, TikTok launched an advertising platform called TikTok Ads. Having such a big, ...

Dupilumab is under clinical development by Regeneron Pharmaceuticals and currently in Phase III for Bullous Pemphigoid. According to GlobalData, Phase III drugs for Bullous Pemphigoid does not have ...

Dupilumab is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Systemic Sclerosis (Scleroderma). According to GlobalData, Phase II drugs for Systemic Sclerosis ...